Human IgG2 kappa, Isotype Control

Human IgG2 kappa, Isotype Control is a chimeric monoclonal antibody recombinantly expressed from HEK293 cells, which is engineered by combining the antigen-binding variable region derived from a mouse monoclonal antibody with the constant domain of a human IgG2 kappa immunoglobulin, thus serving as an immunological control for non-specific binding and Fc receptor interactions.

Anti-EPOR Antibody is a CHO-expressed human antibody targeting EPOR. Its predicted molecular weight (MW) is 150 kDa. For an isotype control, refer to Human IgG2 kappa, Isotype Control.

Anti-CD20 Antibody is a humanized antibody expressed in CHO cells, targeting CD20/MS4A1. It features a huIgG2SA heavy chain and a huκ light chain, with an estimated molecular weight (MW) of 150 kDa. For isotype control, refer to Human IgG2 kappa, Isotype Control.

AMG 317 is a humanized monoclonal antibody targeting CD124/IL4R/IL-4Rα. The recommended isotype control for this compound is HumanIgG2kappa, Isotype Control. It is applicable for research related to asthma.

RG-6125 is a humanized antibody expressed in CHO cells, targeting CDH11/Cadherin-11.

Human IgG1 CH1-Human IgG2 Fc-Kappa Isotype control is the isotype control for Human IgG1 CH1+Human IgG2 Fc-Kappa antibody.

AMG-820 is a human antibody targeting CSF-1R, inhibiting the binding of ligands CSF1 and IL34, and preventing subsequent ligand-induced receptor activation. For AMG-820's isotype control, refer to [Human IgG2 kappa, Isotype Control].